Straumann (OTCMKTS:SAUHY) Sees Strong Trading Volume – Should You Buy?

Straumann Holding AG (OTCMKTS:SAUHY) shares saw an uptick in trading volume on Wednesday . 893,521 shares changed hands during mid-day trading, an increase of 812% from the previous session’s volume of 97,980 shares.The stock last traded at $11.9150 and had previously closed at $11.74.

Analyst Ratings Changes

Several research firms have recently weighed in on SAUHY. UBS Group raised shares of Straumann from a “sell” rating to a “neutral” rating in a research report on Tuesday, November 4th. Deutsche Bank Aktiengesellschaft raised shares of Straumann from a “hold” rating to a “buy” rating in a research note on Friday, October 31st. Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a research report on Monday, December 15th. Finally, Citigroup reissued a “sell” rating on shares of Straumann in a research report on Wednesday, January 14th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, Straumann currently has a consensus rating of “Hold”.

Straumann Stock Performance

The stock has a 50 day moving average price of $12.19 and a two-hundred day moving average price of $11.81.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.